CMND
Clearmind Medicine Inc.
NASDAQ · CAHealthcareBiotechnology
$1.87-3.61%
Price as of Jul 20, 2026
CMND capital
Clearmind Medicine Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.99x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 1.54x
Liquidity & coverage
- Current ratio
- 4.79x
- Quick ratio
- 4.79x
- Cash ratio
- 4.55x
- Interest coverage
- -461.71x
- EBITDA / interest
- -419.02x
- Working capital
- $11.3M
Cash & dividend
- FCF / debt
- -79.02x
- Cash flow / debt
- -79.02x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.